T
he Open Access publication model continues to grow with increased support from the scientific community and funding agencies, including, most recently, the European Commission and the European Research Council. Nephrology is no exception to this trend, which is reflected in the rapid growth in the number of submissions to Kidney International Reports (KI Reports) since our launch in 2016. As we move toward the goal of being the primary Open Access journal for clinical and translational research related to kidney disease, we recognize our responsibility to identify and publish important research, and to ensure its access for clinicians across the globe so they may improve the care of patients with kidney disease.
In 2019, we are introducing several exciting changes for the benefit of both authors and readers. The foremost of these is to change our frequency from 6 times per year to monthly. This increase should further shorten our time to final publication while creating more readable issue sizes. In addition, graphical abstracts ( Figure 1 ), 1 which are now being included with some original investigations, are providing visually appealing summaries that make study findings more accessible to our busy readers. We are
CONCLUSION:
Clinical manifestations and long-term outcomes of IgG4-related kidney and retroperitoneal involvement in a United Kingdom IgG4-related disease cohort IgG4-RKD and IgG4-RPF represent major organ manifestations of IgG4-RD and should be identified early with prompt treatment to prevent progression to ESRD also increasing the number of accompanying expert commentaries in each issue, which will give readers both context and key insights into the implications of important original research. Finally, our strong relationship with Kidney International continues, as selected authors whose rejected papers have been reviewed by Kidney International are given opportunities for an expedited review process should they agree to transfer their manuscripts to us-an option that an increasing number of authors are choosing to do.
To be effective, Open Access publications need to ensure ease of access to research findings. In addition to being indexed in Google Scholar, ScienceDirect, and Scopus, KI Reports has been indexed in PubMed Central since late 2017. All of our issues are currently available on PubMed. Because of the increased use of smartphones and tablets, our accessibility is being further improved with the KI Journals app, which can be downloaded via apps stores for both IOS and Android devices. This easy-to-use feature provides instant access to articles published in both Kidney International and KI Reports.
The editors thank you for the success of KI Reports, as demonstrated by the fact that readers have viewed and downloaded our articles more than 600,000 times to date from the KI Reports and Science Direct web sites since we began publication. This rapid surge in readership across the globe underscores the quality of work being published and the value of our Open Access format. Our growth and evolution are also driven by the continuous support from our Editorial Board members, authors, and peer reviewers. We continue to invite feedback by email at KIreports.editor@cumc. columbia.edu.
We look forward to continuing to serve the nephrology community with the variety of content that lends relevance to everyone from hospital clinicians to researchers to health care providers on the frontlines in both developed and developing nations.
